These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 2843085

  • 21. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
    Gavaldá J, Onrubia PL, Gómez MT, Gomis X, Ramírez JL, Len O, Rodríguez D, Crespo M, Ruíz I, Pahissa A.
    J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
    [Abstract] [Full Text] [Related]

  • 22. Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis.
    Kaatz GW, Seo SM, Reddy VN, Bailey EM, Rybak MJ.
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2081-5. PubMed ID: 1963526
    [Abstract] [Full Text] [Related]

  • 23. Influence of gentamicin dose size on the efficacies of combinations of gentamicin and penicillin in experimental streptomycin-resistant enterococcal endocarditis.
    Wright AJ, Wilson WR, Matsumoto JY, Washington JA, Geraci JE.
    Antimicrob Agents Chemother; 1982 Dec; 22(6):972-5. PubMed ID: 6818902
    [Abstract] [Full Text] [Related]

  • 24. Treatment with imipenem of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis.
    Martínez F, Martín-Luengo F, Garcia A, Valdés M.
    J Antimicrob Chemother; 1994 Jun; 33(6):1201-7. PubMed ID: 7928813
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    Pericàs JM, García-de-la-Mària C, Brunet M, Armero Y, García-González J, Casals G, Almela M, Quintana E, Falces C, Ninot S, Fuster D, Llopis J, Marco F, Moreno A, Miró JM, Hospital Clinic Endocarditis Study Group.
    J Antimicrob Chemother; 2017 Jun 01; 72(6):1714-1722. PubMed ID: 28204495
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Tedizolid as Step-Down Therapy following Daptomycin versus Continuation of Daptomycin against Enterococci and Methicillin- and Vancomycin-Resistant Staphylococcus aureus in a Rat Endocarditis Model.
    Singh KV, Arias CA, Murray BE.
    Antimicrob Agents Chemother; 2020 Apr 21; 64(5):. PubMed ID: 32122892
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
    Hall Snyder A, Werth BJ, Barber KE, Sakoulas G, Rybak MJ.
    J Antimicrob Chemother; 2014 Aug 21; 69(8):2148-54. PubMed ID: 24777900
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Antimicrobial therapy of experimental endocarditis caused by nutritionally variant viridans group streptococci.
    Henry NK, Wilson WR, Roberts RB, Acar JF, Geraci JE.
    Antimicrob Agents Chemother; 1986 Sep 21; 30(3):465-7. PubMed ID: 3777910
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Comparison of penicillin and vancomycin, individually and in combination with gentamicin and amikacin, in the treatment of experimental endocarditis induced by nutritionally variant streptococci.
    Bouvet A, Cremieux AC, Contrepois A, Vallois JM, Lamesch C, Carbon C.
    Antimicrob Agents Chemother; 1985 Nov 21; 28(5):607-11. PubMed ID: 4091526
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.
    López P, Gavaldà J, Martin MT, Almirante B, Gomis X, Azuaje C, Borrell N, Pou L, Falcó V, Pigrau C, Pahissa A.
    Antimicrob Agents Chemother; 2001 May 21; 45(5):1387-93. PubMed ID: 11302800
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.